Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Subunit structure of thrombin-activated human factor VIIIa.

P J Fay1

  • 1Department of Medicine, University of Rochester School of Medicine and Dentistry, NY.

Biochimica Et Biophysica Acta
|January 29, 1988
PubMed
Summary

This study examines how the blood-clotting protein Factor VIII is activated by the enzyme thrombin. Researchers identified that activation creates a specific complex of protein fragments that work together to promote clotting. They also discovered that this active complex is unstable and eventually breaks apart, leading to a loss of function. By using advanced separation techniques, the team mapped the physical size and composition of these protein pieces. These findings help explain the structural basis for how Factor VIII transitions between active and inactive states in the blood.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stabilizing interactions between D666-S1787 and T657-Y1792 at the A2-A3 interface support factor VIIIa stability in the blood clotting pathway.

Journal of thrombosis and haemostasis : JTH·2016
Same author

Enhanced factor VIIIa stability of A2 domain interface variants results from an increased apparent affinity for the A2 subunit. Results from an increased apparent affinity for the A2 subunit.

Thrombosis and haemostasis·2014
Same author

Combining mutations that modulate inter-subunit interactions and proteolytic inactivation enhance the stability of factor VIIIa.

Thrombosis and haemostasis·2014
Same author

Enhancing factor VIII and VIIIa stability by combining mutations at the A2 domain interface and A1-C2 domain interface.

Journal of thrombosis and haemostasis : JTH·2011
Same author

Use of affinity-directed liquid chromatography-mass spectrometry to map the epitopes of a factor VIII inhibitor antibody fraction.

Journal of thrombosis and haemostasis : JTH·2011
Same author

Combining mutations of charged residues at the A2 domain interface enhances factor VIII stability over single point mutations.

Journal of thrombosis and haemostasis : JTH·2008

Area of Science:

  • Hematology research investigating Factor VIIIa subunit architecture
  • Biochemical analysis of protein-protein interactions and proteolysis

Background:

No prior work had fully resolved the precise subunit arrangement of the activated clotting protein Factor VIIIa. That uncertainty drove researchers to investigate how thrombin-mediated cleavage influences the protein's functional state. It was already known that Factor VIII undergoes significant proteolytic processing to gain coagulant activity. Prior research has shown that this activation process generates multiple distinct polypeptide fragments from the original precursor molecule. However, the exact physical association between these resulting fragments remained poorly characterized in the literature. This gap motivated a detailed examination of the molecular architecture following thrombin exposure. Scientists needed to determine which specific fragments constitute the active complex versus those that dissociate upon inactivation. Understanding these structural dynamics is necessary for clarifying the regulation of the human blood coagulation cascade.

Purpose Of The Study:

Keywords:
thrombin activationpolypeptide fragmentsprotein complex stabilitycoagulation cascade

Frequently Asked Questions

The researchers propose that activity stems from a non-covalent dimer formed by 73 kDa and 51 kDa polypeptides. This complex exhibits a Stokes radius of 46 Å, whereas the inactive form involves the dissociation of these specific subunits.

The team utilized gel filtration chromatography and anion-exchange high-performance liquid chromatography. These techniques allowed the separation of the 73/51 kDa active dimer from the 43 kDa fragment and the inactive protein species.

The authors state that chemical crosslinking reagents are necessary to stabilize the labile activity. This process presumably functions by creating intra-chain crosslinks, preventing the spontaneous decay of the active dimer into its inactive, dissociated components.

Related Experiment Videos

The aim of this study is to define the subunit structure of the activated human blood clotting protein Factor VIIIa. Researchers sought to clarify how proteolytic processing by thrombin generates specific polypeptide fragments. The investigation addresses the uncertainty regarding which fragments remain associated to form the functional coagulant complex. Scientists intended to distinguish the active dimer from inactive forms produced during the clotting cascade. This work explores the physical properties, including molecular weight and Stokes radii, of the resulting protein subunits. The team examined the stability of these associations to understand why the protein activity decays over time. By mapping these structural relationships, the study provides insight into the regulation of blood clotting. The motivation is to resolve the molecular architecture that enables the protein to function effectively in the human body.

Main Methods:

Review approach involved the application of two rapid chromatographic techniques to isolate protein fragments. Researchers utilized gel filtration to determine the physical size of the complexes based on Stokes radii. Anion-exchange high-performance liquid chromatography served to resolve active dimers from inactive species. The team assessed the impact of EDTA on the stability of the polypeptide associations. Chemical crosslinking reagents were applied to investigate the potential for stabilizing the labile active form. Sedimentation coefficients were measured to provide data for calculating the native molecular weight of the complex. The investigation compared the elution patterns of thrombin-activated samples against those subjected to prolonged incubation. This systematic approach allowed for the precise identification of the polypeptide components within the active dimer.

Main Results:

Key findings from the literature demonstrate that coagulant activity correlates with a complex of 73 kDa and 51 kDa polypeptides. These two fragments co-elute with a Stokes radius of 46 Å during gel filtration. The 43 kDa fragment consistently separates from this active dimer during the chromatographic process. Anion-exchange high-performance liquid chromatography successfully resolves the active 73/51 kDa dimer from the inactive protein species. The study reports a native molecular weight of 136,000 for the active complex. EDTA-inactivated samples reveal that the 73 kDa and 51 kDa subunits elute separately with radii of 32 Å and 38 Å. Prolonged thrombin incubation results in a polypeptide elution pattern similar to the inactive form. Chemical crosslinking effectively prevents the decay of the labile activity observed in the native complex.

Conclusions:

The authors propose that the active form of the protein functions as a non-covalent dimer. This complex consists specifically of the 73 kDa and 51 kDa polypeptide subunits. The researchers conclude that the loss of coagulant activity correlates with the dissociation of these components. Their data suggest that chemical crosslinking can successfully stabilize the otherwise labile active complex. The study indicates that the 43 kDa fragment does not participate in the primary coagulant-active dimer. Synthesis and implications reveal that the native molecular weight of the active complex is approximately 136,000. The team suggests that the inactive form arises from the separation of these subunits rather than further proteolysis. These findings provide a structural framework for understanding the transient nature of blood clotting activation.

The researchers used the Stokes radius of 46 Å and a sedimentation coefficient of 7.1 S. These values allowed for the calculation of a native molecular weight of 136,000, confirming the dimer structure.

The study measured the Stokes radius of the subunits using EDTA-inactivated samples. The 73 kDa polypeptide showed a radius of 32 Å, while the 51 kDa polypeptide measured 38 Å, demonstrating their independent elution.

The authors imply that the instability of the active complex is a regulatory feature. They suggest that the decay to an inactive form occurs through subunit dissociation, which limits the duration of the clotting response in the blood.